Exhibit 107

Calculation of Filing Fee Table

Table 1 - Transaction Valuation

	Transaction     Valuation	Fee     Rate	Amount of     Filing Fee
Fees to Be Paid	$27,628,553.19 (1)	0.00011020	$3,044.67 (2)
Fees Previously Paid	—		—
Total Transaction Valuation	$27,628,553.19
Total Fees Due for Filing			$3,044.67
Total Fees Previously Paid			$0
Total Fee Offsets			$0
Net Fee Due			$3,044.67

(1) For purposes of calculating the filing fee pursuant to Rule 0-11(d) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Transaction Valuation was calculated by adding (i) the product of (A) 30,358,385 shares, which is the total number of shares of common stock of Satsuma Pharmaceuticals, Inc. outstanding (“Shares”) not beneficially owned by SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. (calculated as the difference between 33,152,498, the total number of outstanding Shares, and 2,794,113, the number of Shares beneficially owned by SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. as of April 14, 2023) and (B) $0.91, which is the per Share tender offer price, and (ii) the product of (A) 242,284, which is the number of Shares issuable upon the exercise of vested “in-the-money” options to purchase the Shares, and (B) $0.01, which is the difference between $0.91, which is the per Share tender offer price, and $0.90, which is the weighted average per share exercise price of such options. The calculation of the Transaction Valuation is based on information provided by Satsuma Pharmaceuticals, Inc. as of April 14, 2023, the most recent practicable date.

(2) The amount of the filing fee was calculated in accordance with Rule 0-11 of the Exchange Act and Fee Rate Advisory # 1 for Fiscal Year 2023 issued by the Securities and Exchange Commission (the “Commission”), by multiplying the Transaction Valuation by 0.00011020.